Small firm, broad services Synovel Laboratory operates as a small-scale integrated CRO offering medicinal chemistry, process chemistry, analytical development, and regulatory support, presenting opportunities to become a flexible, cost-efficient partner for pharma startups and mid-stage companies seeking end-to-end R&D assistance.

IND enablement ready With capabilities spanning process optimization, salt and polymorph analysis, kg-scale non-GMP intermediate production, and DMPK regulatory support including IND/BLA/NDA documentation, there is a clear path to assist clients preparing for IND submissions or scale-up transitions.

Regulatory & PK support Offering GLP-compliant bioanalysis tools, PK consulting, and regulatory document preparation positions Synovel as a compatible adjunct for sponsors needing regulatory strategy alignment and submission-ready data packages.

Revenue growth potential Current revenue is under one million dollars, suggesting a high-growth potential through expanded client acquisition, expanded service lines, and leveraging its full-service medicinal chemistry and analytical capabilities to win more CRO contracts.

Strategic partnerships Target firms in early drug discovery and development stages, including small biotechs and virtual pharma companies, by highlighting integrated offerings, flexible scalability, and rapid turnaround for milestones such as preclinical milestones and IND preparation.